Year: 2020
Type: article
Abstract: Increasingly, patients with decompensated rheumatologic and autoimmune diseases and with imminent vital commitment to intensive care units are more frequent, in addition to supporting the organic failures that threaten the lives of these patients, care must be taken to control and stop the catastrophe established organic, for this the steroids are first-line drugs, alone, or in conjunction with other immunomodulatory / immunosuppressive drugs. However, when resorting to steroids at conventional doses orally / intravenously or when administering pulses (megadoses)?. In this review, we will try to answer this question with the best available evidence and try to deliver a decision-making tool for the physicians who care for these patients.
Source: Avances en Biomédicina
Authors: Jorge Luis Vélez Páez, A Fernando Martinez
Institution: Pontificia Universidad Católica del Ecuador
Language: Spanish
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W3008963969
